Methodological issues related to assessing and measuring quality of life in patients with cancer: implications for patient care

European Journal of Cancer Care
C McCabeS McCann

Abstract

Consideration of quality-of-life issues by all members of the healthcare team is essential in caring for people with cancer. In cancer research, quality of life is generally classified as health-related quality of life or individual quality of life. This paper discusses the instruments used to measure quality-of-life outcomes, and the relevance of such findings for healthcare staff in planning and providing effective and patient-centred care. Visual analogue scales (VASs) and questionnaires are commonly used to measure quality of life; however, both types of instruments are criticized because the content may not be relevant to individual patients, and do not distinguish differences between statistical and clinical significances in the findings. Using a combination of questionnaires and VASs may overcome some of these criticisms. In order to interpret the difference between statistical and clinical significance of findings and the associated implications for patient care, a mixed-methods approach to data collection is recommended in quality-of-life studies. This provides meaning and understanding to the quantitative data and individual perspectives on patients' experiences of having cancer. Information from such studies may also...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Jan 1, 1981·Journal of Chronic Diseases·W O SpitzerB R Catchlove
Oct 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·P HopwoodD Machin
Feb 1, 1993·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B BrorssonR D Hays
Jun 1, 1996·Journal of Advanced Nursing·K A LukerR G Owens
Feb 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S M GrunbergB Meyerowitz
Feb 1, 1997·International Journal of Nursing Studies·C BerteröA C Ek
May 1, 1997·The American Journal of Psychiatry·H M ChochinovS Lander
Apr 1, 1997·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·R J StephensD Machin
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SloanN L Vaught
Sep 9, 1999·Acta Neurologica Scandinavica·L E PfenningsL Vleugels
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D WaldronD Carney
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Osoba
Apr 29, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J de HaesA Cull
Jul 13, 2000·European Journal of Cancer Care·K MagnussonA Wallgren
Dec 21, 2000·Statistics in Medicine·E Svensson
Feb 17, 2001·Psycho-oncology·J Brennan
May 5, 2001·British Journal of Cancer·J BernhardC M Rudenstam
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BernhardUNKNOWN Swiss Group for Clinical Cancer Research
Jan 31, 2002·Oncology Nursing Forum·Marie-Claire Richer, Hélène Ezer
Feb 6, 2002·European Journal of Cancer Care·L PerssonI R Hallberg
Feb 20, 2002·The British Journal of Surgery·W SchwenkJ M Müller
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeff A SloanCharles L Loprinzi
Apr 9, 2002·Mayo Clinic Proceedings·Gordon H GuyattUNKNOWN Clinical Significance Consensus Meeting Group
Apr 9, 2002·Mayo Clinic Proceedings·David CellaUNKNOWN Clinical Significance Consensus Meeting Group
Apr 19, 2002·The Oncologist·Andrew Bottomley
Apr 23, 2002·European Journal of Cancer Care·C KellyK Caldwell
Jun 25, 2002·Bone Marrow Transplantation·P C TraskJ Ferrara
Jul 12, 2002·Psycho-oncology·Charles MontgomeryKeith Lloyd
Nov 26, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C R R MirandaH Friedman
May 29, 2003·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Geoffrey Norman
Jul 2, 2003·Psycho-oncology·Mary Carmen Xuereb, Rosemary Dunlop
Jan 7, 2004·Australian and New Zealand Journal of Public Health·Jeff DunnBeth Newman
Apr 1, 2004·Psycho-oncology·Mark R KatzGeorge Tomlinson
Apr 17, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A G E M de BoerM A G Sprangers

❮ Previous
Next ❯

Citations

Jun 16, 2009·Current Oncology·R Thomas-MacleanP Graham
Dec 20, 2015·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·Ibrahim K Abu-GhoriG Hussein Rassool
Jan 31, 2014·Research in Gerontological Nursing·Eileen Danaher HackerSandra C Burgener

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.